Compound Evidence File
#EC-2026-0322
PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6
Filed under Raw Materials. The bureau holds 87 laboratory returns for this compound from 25 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
25 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 6 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Henan Sahe PeptideCASE #VI-2026-0894 | X | 1 | 9.9 | 9.9 | 9.9 | 20 Jun 2025 | 20 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 9.2 | 8.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Leader Peptide BiotechnologyCASE #VI-2026-0558 | X | 1 | 9.0 | 9.0 | 9.0 | 27 Feb 2025 | 27 Feb 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 9.0 | 9.0 | 9.0 | 9 Jun 2025 | 9 Jun 2025 |
| Qingdao Saber Technology Pharma QSTCASE #VI-2026-0467 | X | 1 | 8.9 | 8.9 | 8.9 | 24 Apr 2025 | 24 Apr 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.5 | 7.3 | 9.4 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 8 | 8.3 | 7.6 | 9.4 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 7 | 8.2 | 6.3 | 10.0 | 24 May 2026 | 24 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 5 | 8.0 | 7.1 | 9.0 | 21 May 2026 | 21 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 5 | 7.8 | 6.4 | 9.6 | 2 Apr 2025 | 25 May 2026 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 3 | 7.3 | 4.8 | 10.0 | 3 Jun 2025 | 21 May 2026 |
| Peptide WorldwideCASE #VI-2026-0217 | X | 1 | 6.9 | 6.9 | 6.9 | 3 Jul 2025 | 3 Jul 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 14 | 6.4 | 3.8 | 8.0 | 2 Apr 2025 | 24 May 2026 |
| NexaphCASE #VI-2026-0944 | X | 8 | 6.2 | 3.1 | 9.2 | 8 Jul 2025 | 24 May 2026 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 1 | 6.0 | 6.0 | 6.0 | 27 Feb 2025 | 27 Feb 2025 |
| Amino LairCASE #VI-2026-0413 | X | 1 | 5.9 | 5.9 | 5.9 | 27 Feb 2025 | 27 Feb 2025 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 5.7 | 5.7 | 5.7 | 17 Dec 2024 | 17 Dec 2024 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 5.1 | 5.1 | 5.1 | 21 May 2025 | 21 May 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 4.4 | 4.4 | 4.4 | 16 Mar 2025 | 16 Mar 2025 |
| InjectifyCASE #VI-2026-0387 | X | 1 | 3.8 | 3.8 | 3.8 | 3 Jun 2025 | 3 Jun 2025 |
| Royal PeptidesCASE #VI-2026-0264 | X | 2 | 3.7 | 2.6 | 4.7 | 2 Jul 2025 | 23 May 2026 |
| Peptide GurusCASE #VI-2026-0854 | X | 2 | 3.6 | 3.2 | 4.0 | 6 May 2025 | 21 May 2026 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 2.8 | 2.8 | 2.8 | 2 Apr 2025 | 2 Apr 2025 |
Open any subject to view the batch-level evidence for PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 alone.